Skip to main content
a b c d e f g h i j k l m n o p q r s t u v w x y z #

Items starting with L

Lactate

Lactate

<16yrs   0.6-2.5 mmol/L    (Source : Pathology Harmony Recommendations)

Adult      0.5-2.2 mmol/L   (Source : Abbott Diagnostics)

CSF lactate-age related: 1.1-6.7mmol/L (neonates) 1.1-2.4 mmol/L (adults) 

Lactate Dehydrogenase (LDH)

Lactate Dehydrogenase (LDH)

125-220 IU/L (Enzyme activity not reported on haemolysed samples)

Source : Abbott Diagnostics

Lamotrigine (Lamictal)

Lamotrigine (Lamictal)

Therapeutic range (epilepsy): 1 - 4 mg/L

Maximum drug efficacy (bipolar disorder): 3 - 14 mg/L

Lead

Lead

Normal values: <0.24 umol/L

Desirable values in children: <0.24 umol/L

Occupational Certification Limit for women of reproductive capacity: 1.45 umol/L

Occupational Certification Limit for males (age 18+): 2.90 umol/L

INDUSTRIAL EXPOSURE

 

Repeat within 12 months

< 1.4

Repeat within 6 months

> 1.4 – 1.9

Repeat within 3 months

> 1.9 – 2.4

Repeat within 3 months

> 2.4 – 2.9

At doctors discretion but not more than 3 months

> 2.9

Please note that the normal values have been decreased as of 2018 to bring us in-line with CDC recommendations.

Levetiracetam (Keppra)

Levetiracetam (Keppra)

There is no evidence to justify monitoring of Levetiracetam other than to assess adherence, though a range of 6 – 20 mg/L has been suggested. Renal excretion means that the plasma half-life is longer in the elderly. Dose reduction is necessary at GFR < 60 mL/min/1.73 m2.

Levetiracetam (Keppra)

Levetiracetam (Keppra)

There is no evidence to justify monitoring of Levetiracetam other than to assess adherence, though a range of 6 – 20 mg/L has been suggested. Renal excretion means that the plasma half-life is longer in the elderly. Dose reduction is necessary at GFR < 60 mL/min/1.73 m2.

Lipoprotein a (Lp (a))

Lipoprotein a (Lp (a))

Increased coronary risk over 75 nmol/L.

[12  >>